Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: prev dose administration date=14Mar2021, dose number=2 administration date=06Oct2021; Inflammatory Sporadic pain-back, chest hand; Inflammatory Sporadic pain-back, chest hand; Inflammatory Sporadic pain-back, chest hand; Inflammatory Sporadic pain-back, chest hand; Brain Fog; Toe Hematoma; Fatigue; Shortness of breath; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 53 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Oct2021 12:15 (Lot number: FF2590) at the age of 53 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Hyperlipidemia" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6204, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM, Verbatim:Inflammatory Sporadic pain-back, chest hand), administration date: 14Mar2021, when the patient was 52 years old, for Covid-19 Immunization, reaction(s): "Inflammatory Sporadic pain-back, chest hand", "Inflammatory Sporadic pain-back, chest hand", "Inflammatory Sporadic pain-back, chest hand", "Inflammatory Sporadic pain-back, chest hand", "Brain Fog", "Toe Hematoma", "Fatigue", "Shortness of breath". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 06Oct2021, outcome "unknown", described as "prev dose administration date=14Mar2021, dose number=2 administration date=06Oct2021"; INFLAMMATION (non-serious), BACK PAIN (non-serious), CHEST PAIN (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 2021, outcome "unknown" and all described as "Inflammatory Sporadic pain-back, chest hand"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Brain Fog"; HAEMATOMA (non-serious) with onset 2021, outcome "unknown", described as "Toe Hematoma"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "Fatigue"; DYSPNOEA (non-serious) with onset 2021, outcome "unknown", described as "Shortness of breath". The events "inflammatory sporadic pain-back, chest hand", "inflammatory sporadic pain-back, chest hand", "inflammatory sporadic pain-back, chest hand", "inflammatory sporadic pain-back, chest hand", "brain fog", "toe hematoma", "fatigue" and "shortness of breath" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of inflammation, back pain, chest pain, pain in extremity, feeling abnormal, haematoma, fatigue, dyspnoea.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No hospitalization required or prolonged. No seriousness provided. No known allergies. Prior to vaccination, was the patient diagnosed with COVID-19?:No. Since the vaccination, has the patient been tested for COVID-19?:Yes  No follow-up attempts are possible. No further information is expected.